Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CES2 | O00748 | 4/20 | 0.62 |
| ▸ | CES1 | P23141 | 4/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2782616 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL6840834 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL105548 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL811181 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL19629035 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL632531 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL1153187 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044695 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044630 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL966153 | 1.00 | KMT2A (0.65) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509607-B2 | Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2025-12-30 | — | — | US | claimed |
| CN-118344298-A | Continuous preparation method of trealsil key intermediate | 南京威凯尔生物医药科技有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-115105967-B | Acid-resistant alkali-resistant nanofiltration membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-112384509-B | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117486812-A | Method for preparing 1, 4-diazaspiro [5.5] undecane-3-one by fixed bed hydrogenation | 杭州国瑞生物科技有限公司 | 2024-02-02 | — | — | CN | claimed |
| WO-2024017358-A1 | MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 贝达药业股份有限公司 | 2024-01-25 | — | — | WO | claimed |
| CN-117396590-A | Perfume for improving relaxation state and evaluation method | 奇华顿股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-112601731-B | Synthesis of cyclopentenone | 陶氏环球技术有限责任公司 | 2023-10-03 | — | — | CN | claimed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | claimed |
| US-20230159784-A1 | METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2023-05-25 | — | — | US | claimed |
| WO-2000010561-A1 | BIO-CHEMICAL GERMANIUM COMPLEXES WITH HIGH THERAPEUTIC EFFICIENCY AND WIDE APPLICATION SPECTRUM | SOLOVIEV EVGENY VLADIMIROVICH (FR) | 2000-03-02 | — | — | WO | claimed |
| EP-0916668-A1 | CHEMOKINE RECEPTOR ANTAGONISTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-05-19 | — | — | EP | claimed |
| EP-0772609-B1 | CYCLIC KETONE PEROXIDE FORMULATIONS | AKZO NOBEL NV (NL) | 1999-02-24 | — | — | EP | claimed |
| US-5808110-A | TRANSPORTABLE; STORAGE STABLE | AKZO NOBEL NV (NL) | 1998-09-15 | — | — | US | claimed |
| EP-0772609-A1 | CYCLIC KETONE PEROXIDE FORMULATIONS | Akzo Nobel N.V. (NL) | 1997-05-14 | — | — | EP | claimed |
| WO-1996003397-A1 | CYCLIC KETONE PEROXIDE FORMULATIONS | AKZO NOBEL N.V. (NL) | 1996-02-08 | — | — | WO | claimed |
| EP-0285018-A2 | Substituted 9-Amino-Spiro [cycloalkyl[b]quinoline-2,1'cycloalkanes], a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1988-10-05 | — | — | EP | claimed |
| US-4533742-A | USING RHODIUM CARBONYL CATALYST | TEXACO INC. (US) | 1985-08-06 | — | — | US | claimed |
| EP-0074693-A1 | Perfume compositions and perfumed articles containing spiro-undecanones and -undecenones as perfume base | NAARDEN INTERNATIONAL N.V. (NL) | 1983-03-23 | — | — | EP | claimed |
| US-4304939-A | Preparation of N-phenyl-N-alkylphenylenediamines | UOP INC. (US) | 1981-12-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509607-B2 | Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material | RPS28, RPS27, RPS27L | KMT2A 3525/4885MAPT 377/4885CES2 2777/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | KMT2A 4388/4885MAPT 2487/4885CES2 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.